Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
2019-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a49333859c395e5e8f66cb35f57f9ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7083fe6d42ef1afa68959c51a8b608f5 |
publicationDate |
2020-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-202039497-A |
titleOfInvention |
7-(methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives |
abstract |
The present invention provides a compound of Formula I: nwherein R is or ;nor a pharmaceutically acceptable salt thereof, useful for treating psoriasis or systemic lupus erythematosus. |
priorityDate |
2018-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |